A researcher blocks PRPP synthesis in a cell. Compared to purine biosynthesis, how does pyrimidine biosynthesis respond differently to this block?
APyrimidine biosynthesis is unaffected — it does not use PRPP at any stage
BPyrimidine biosynthesis is blocked at an earlier step than purine biosynthesis, because PRPP is needed before ring formation in purines but only after ring formation in pyrimidines
CBoth pathways are equally blocked, since PRPP is essential to both — but pyrimidines are blocked specifically at the step where orotate receives its ribose group
DOnly purine biosynthesis is blocked — pyrimidines use a different ribose donor
This question tests the key structural distinction: purines build their ring *on* PRPP (ribose is the scaffold from the start), so PRPP is needed at the very beginning. Pyrimidines build the complete ring (orotate) first, then attach it to PRPP to form orotidylate (OMP). So in both cases PRPP is essential, but it enters the pyrimidine pathway later — after the ring is already assembled. The point is that the ring-first vs. sugar-first distinction affects *where* PRPP blocks each pathway.
Question 2 Multiple Choice
In mammalian cells, excess UTP accumulates. Which enzyme is most directly inhibited, and what is the functional consequence?
AATCase is inhibited — the same feedback as in bacteria, preventing carbamoyl phosphate condensation
BCarbamoyl phosphate synthetase II (CPS II) is inhibited — shutting down de novo pyrimidine synthesis at the first committed step
CUMPS is inhibited — preventing conversion of orotidylate to UMP
DThymidylate synthase is inhibited — blocking DNA-specific pyrimidine production
In mammals, the primary regulatory enzyme is carbamoyl phosphate synthetase II (CPS II), which is inhibited by UTP (and activated by PRPP). This differs from bacteria, where ATCase is the regulated step. UTP accumulation signals sufficient pyrimidine pools and throttles the first committed step, preventing wasteful overproduction. ATCase is the bacterial regulatory target — a classic exam trap that confuses the two organisms' regulatory strategies.
Question 3 True / False
Pyrimidine biosynthesis assembles the six-membered ring on a ribose scaffold before releasing the completed nucleotide.
TTrue
FFalse
Answer: False
This is exactly backward. Pyrimidine biosynthesis builds the complete six-membered ring (orotate) *first*, in free form without any sugar. Only after orotate is fully formed does it react with PRPP to receive its ribose-5-phosphate group, producing orotidylate (OMP). This ring-first, sugar-second sequence is the defining structural difference from purine biosynthesis, where the purine ring is assembled step-by-step on a ribose scaffold from the beginning.
Question 4 True / False
The anticancer drugs methotrexate and 5-fluorouracil both ultimately impair the production of dTMP, the thymine nucleotide needed for DNA synthesis.
TTrue
FFalse
Answer: True
Both drugs target the thymidylate synthesis pathway. Thymidylate synthase converts dUMP to dTMP using N⁵,N¹⁰-methylene-tetrahydrofolate as both a one-carbon donor and a reductant. 5-fluorouracil (as its active metabolite FdUMP) is a suicide inhibitor of thymidylate synthase itself. Methotrexate blocks dihydrofolate reductase (DHFR), which is needed to regenerate the tetrahydrofolate cofactor after it is oxidized in the thymidylate synthase reaction. Both drugs deplete the cell's supply of dTMP, stalling DNA replication — particularly in rapidly dividing cancer cells.
Question 5 Short Answer
What is the fundamental structural difference between how pyrimidine and purine rings are synthesized, and why does this matter for understanding the pathway?
Think about your answer, then reveal below.
Model answer: Purine rings are built incrementally on a ribose scaffold (sugar-first): PRPP is the starting material and the ring is assembled atom-by-atom on top of it. Pyrimidine rings are assembled as free molecules first (ring-first): the complete six-membered pyrimidine ring (orotate) is synthesized from carbamoyl phosphate and aspartate without any sugar, and ribose is attached only afterward when orotate reacts with PRPP. This means blocking early steps in pyrimidine synthesis prevents ring formation entirely, while blocking early purine steps prevents sugar attachment.
Knowing which comes first — ring or sugar — helps predict where specific inhibitors act, how the pathways share or diverge at PRPP, and why the regulatory points differ. The ring-first strategy of pyrimidines means that the pathway can be blocked completely before any PRPP is consumed, whereas purine synthesis immediately commits PRPP at the first step.